| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edgewise Therapeutics, Inc. (EWTX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. EWTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 262.5K | $9.27M | - | |
| Other | 105.0K | $3.71M | - | |
| Dir | 45.1K | $1.59M | - | |
| CEO | 38.6K | $1.36M | - | |
| Dir | 30.0K | $1.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | Russell Alan J77 | Chief Scientific Officer | Sale+OE | 200 | $30.02 | $6,004.00 | -1.3% | -47.1% | -0.7% | |
| Mar 7, 2025 | Koch Kevin55 | President And CEO | Sale+OE | 100 | $30.00 | $3,000.00 | -0.7% | -47.1% | -0.7% | |
| Feb 6, 2025 | Russell Alan J77 | Chief Scientific Officer | Sale+OE | 9,215 | $30.04 | $276,776.12 | -23.7% | -49.4% | +1.4% | |
| Feb 6, 2025 | Koch Kevin55 | President And CEO | Sale+OE | 9,536 | $30.13 | $287,315.62 | -24.8% | -49.4% | +1.4% | |
| Feb 5, 2025 | Derakhshan Behrad52 | Chief Business Officer | Sale+OE | 10,000 | $30.03 | $300,300.00 | -37.3% | -52.1% | -9.5% | |
| Jan 28, 2025 | Donovan Joanne M.49 | CMO | Sale+OE | 25,000 | $27.63 | $690,657.50 | -60.4% | -43.6% | +3.2% | |
| Dec 30, 2024 | Russell Alan J77 | Chief Scientific Officer | Sale+OE | 100,000 | $27.37 | $2,737,470.00 | -87.1% | -18.7% | -9.3% | |
| Dec 24, 2024 | Semigran Marc | Chief Development Officer | Sale+OE | 29,709 | $29.69 | $881,915.22 | -66.2% | -21.1% | -7.9% | |
| Sep 23, 2024 | Moore John R45 | General Counsel | Sale+OE | 70,922 | $28.15 | $1,996,574.40 | -91.6% | +13.2% | -43.0% | |
| Sep 20, 2024 | Russell Alan J77 | Chief Scientific Officer | Sale+OE | 75,000 | $28.27 | $2,120,101.20 | -74.1% | +8.9% | -49.6% |